Organos

Developer of cardiac micro physiological systems designed to offer 3D human cardiac tissue models for advanced analysis. The company’s data science ecosystem uses to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, enabling the health industry to perform safer and cheaper drug development activities.